Cigna-Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June

High- and low-concentration interchangeable biosimilar will be available, estimated to save individual patients around $3,500 on average per year Biosimilar price will be about 85% lower than Humira®* BLOOMFIELD, Conn., April 25, 2024 /PRNewswire/ -- In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar available for$ 0 out of pocket for eligible patients of its speci ...